AU2021902179A0 - Treatment of Glaucoma - Google Patents

Treatment of Glaucoma

Info

Publication number
AU2021902179A0
AU2021902179A0 AU2021902179A AU2021902179A AU2021902179A0 AU 2021902179 A0 AU2021902179 A0 AU 2021902179A0 AU 2021902179 A AU2021902179 A AU 2021902179A AU 2021902179 A AU2021902179 A AU 2021902179A AU 2021902179 A0 AU2021902179 A0 AU 2021902179A0
Authority
AU
Australia
Prior art keywords
glaucoma
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2021902179A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Macquarie University
Original Assignee
Macquarie University
Filing date
Publication date
Application filed by Macquarie University filed Critical Macquarie University
Publication of AU2021902179A0 publication Critical patent/AU2021902179A0/en
Priority to PCT/AU2021/051524 priority Critical patent/WO2022133521A1/en
Priority to US18/268,203 priority patent/US20240067703A1/en
Abandoned legal-status Critical Current

Links

AU2021902179A 2020-12-21 2021-07-15 Treatment of Glaucoma Abandoned AU2021902179A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/AU2021/051524 WO2022133521A1 (en) 2020-12-21 2021-12-20 Treatment of glaucoma
US18/268,203 US20240067703A1 (en) 2020-12-21 2021-12-20 Treatment of glaucoma

Publications (1)

Publication Number Publication Date
AU2021902179A0 true AU2021902179A0 (en) 2021-07-29

Family

ID=

Similar Documents

Publication Publication Date Title
EP3829569A4 (en) Spinosyn formulations for treatment of demodex-induced ocular and facial conditions
EP3977199A4 (en) Electrically-tunable vision aid for treatment of myopia
EP4100406A4 (en) Compositions for treatment of ocular diseases
EP3866790A4 (en) Methods and compositions for treatment of glaucoma and related conditions
AU2021902179A0 (en) Treatment of Glaucoma
AU2020904767A0 (en) Treatment of Glaucoma
EP4065106A4 (en) Methods of treating hiv-1 infection
EP3914263A4 (en) Methods and compositions for the treatment and prevention of ocular diseases and conditions
EP3990457A4 (en) Compounds for treatment of eye disorders
EP3917625A4 (en) Novel treatments of glaucoma
AU2022900727A0 (en) Methods of treating glaucoma
AU2021903030A0 (en) Methods of treatment
AU2021902512A0 (en) Methods of treatment
AU2021900789A0 (en) Methods of treatment
AU2021900740A0 (en) Combination Methods of Treatment
AU2020903332A0 (en) Methods of treatment
AU2020902585A0 (en) Methods of treatment
AU2020900580A0 (en) Methods of Treatment
AU2023902382A0 (en) Methods of treatment
AU2020904714A0 (en) Treatment of covid-19 with rebamipide
AU2021903178A0 (en) Treatment of VEGFA-Related Disease
AU2020903576A0 (en) Treatment of VEGFA-Related Disease
EP4034125A4 (en) Treatment of excitotoxicity-related conditions
AU2023903453A0 (en) Treatment of Malaria
AU2019903588A0 (en) Treatment of excitotoxicity-related conditions